Eribulin

41 interactions 3 explained in plain English

Also sold as: Halaven

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Sertraline Oxaliplatin Injection Relugolix Glasdegib Foscarnet Injection Bedaquiline

41 Major

All (41) Major (41)

Major

Eribulin Sertraline Explained An increased risk of QT interval prolongation Details Eribulin Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Eribulin Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Eribulin Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Eribulin Arsenic Trioxide Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Eribulin Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Eribulin Arsenic Trioxide Injection Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Eribulin Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Eribulin Azithromycin AzaSite An increased risk of QT interval prolongation and torsade de pointes Details Eribulin Anagrelide Agrylin Increased risk of QT interval prolongation Details Eribulin Bedaquiline Sirturo Increased risk of QT interval prolongation Details Eribulin Chloroquine Aralen® Increased risk of QT-interval prolongation Details Eribulin Dasatinib Phyrago An increased risk of QT interval prolongation Details Eribulin Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Eribulin Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Eribulin Dofetilide Tikosyn An increased risk of QT interval prolongation Details Eribulin Encorafenib Braftovi Increased risk of QT interval prolongation Details Eribulin Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Eribulin Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Eribulin Fostemsavir Rukobia Increased risk of torsade de pointes Details Eribulin Glasdegib Daurismo Increased risk of QT interval prolongation Details Eribulin Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Eribulin Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Eribulin Hydroxychloroquine Plaquenil Increased risk of QT interval prolongation Details Eribulin Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Eribulin Ivabradine Corlanor Increased risk of QT prolongation Details Eribulin Ketoconazole Topical Extina® Foam Increased risk for QT interval prolongation Details Eribulin Lefamulin Xenleta Increased risk of QT interval prolongation Details Eribulin Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Eribulin Levofloxacin Levaquin Increased risk of QT interval prolongation Details Eribulin Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Eribulin Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Eribulin Metronidazole Flagyl An increased risk of QT interval prolongation Details Eribulin Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Eribulin Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Eribulin Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Eribulin Moxifloxacin Avelox Increased risk of QT interval prolongation Details Eribulin Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Eribulin Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Eribulin Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.